Iovance Biotherapeutics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Iovance Biotherapeutics Inc IOVA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.13 -0.25% 50.93 20:00:00
Open Price Low Price High Price Close Price Prev Close
52.00 50.43 53.005 50.93 51.06
more quote information »

Recent News

Date Time Source Heading
1/19/202108:56GLOBEIovance Biotherapeutics to Present at Upcoming Healthcare..
1/11/202114:22EDGARStatement of Ownership (sc 13g)
1/06/202117:02EDGARStatement of Changes in Beneficial Ownership (4)
1/06/202117:02EDGARStatement of Changes in Beneficial Ownership (4)
1/06/202117:01EDGARStatement of Changes in Beneficial Ownership (4)
12/28/202007:30GLOBEIovance Biotherapeutics to Present at the 39th Annual J.P...
12/14/202017:16EDGARCurrent Report Filing (8-k)
12/14/202007:00GLOBEIovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief..
11/30/202007:21GLOBEIovance Biotherapeutics to Present at Upcoming Conferences..
11/09/202008:00GLOBEIovance Biotherapeutics Presents Clinical Data in Head and..
11/05/202016:07EDGARCurrent Report Filing (8-k)
11/05/202016:00GLOBEIovance Biotherapeutics Reports Third Quarter and..
10/30/202007:00GLOBEIovance Biotherapeutics to Host Third Quarter 2020 Financial..
10/28/202007:45GLOBEIovance Biotherapeutics to Present at Upcoming Conferences..
10/14/202017:07EDGARCurrent Report Filing (8-k)
10/14/202017:01GLOBEIovance Biotherapeutics to Present Clinical Data in Head and..
10/06/202007:00GLOBEIovance Biotherapeutics to Present at Upcoming October..
10/05/202017:17EDGARCurrent Report Filing (8-k)
10/05/202016:01GLOBEIovance Biotherapeutics Provides Update for Lifileucel in..
8/07/202007:30GLOBEIovance Biotherapeutics to Present at BTIG Biotechnology..
8/06/202017:19EDGARQuarterly Report (10-q)
8/06/202016:06EDGARCurrent Report Filing (8-k)
8/06/202016:01GLOBEIovance Biotherapeutics Reports Second Quarter 2020..
8/06/202008:05GLOBEAvid Bioservices Selected By Iovance Biotherapeutics to Lead..
7/23/202007:30GLOBEIovance Biotherapeutics to Host Second Quarter 2020..
6/19/202016:47EDGARSecurities Registration: Employee Benefit Plan (s-8)
6/12/202017:16EDGARCurrent Report Filing (8-k)
6/09/202017:21EDGARCurrent Report Filing (8-k)
6/08/202016:01GLOBEIovance Biotherapeutics to Present at Upcoming June..
6/02/202019:20EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202016:57EDGARCurrent Report Filing (8-k)
6/02/202016:01GLOBEIovance Biotherapeutics, Inc. Announces Closing of $603.7..
5/29/202016:24EDGARCurrent Report Filing (8-k)
5/29/202016:16EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/29/202008:01GLOBEIovance Presents Updated Clinical Data for Tumor..
5/28/202021:30GLOBEIovance Biotherapeutics, Inc. Announces Pricing of Its..
5/27/202017:26EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/27/202016:20GLOBEIovance Biotherapeutics, Inc. Announces Proposed Public..
5/27/202016:15EDGARAutomatic Shelf Registration Statement of Securities of..
5/27/202016:03EDGARCurrent Report Filing (8-k)
5/27/202016:01GLOBEIovance Reports Pivotal Cohort 4 Data for Tumor Infiltrating..
5/22/202016:32EDGARCurrent Report Filing (8-k)
5/13/202017:01GLOBEIovance Biotherapeutics Announces Clinical Data Updates for..
5/08/202017:19EDGARCurrent Report Filing (8-k)
5/05/202017:19EDGARQuarterly Report (10-q)
5/05/202016:32EDGARCurrent Report Filing (8-k)
5/05/202016:01GLOBEIovance Biotherapeutics Reports First Quarter 2020 Financial..
4/29/202012:01GLOBEIovance Biotherapeutics to Present Updated Data from..
4/28/202017:19EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/27/202017:01EDGARProxy Statement (definitive) (def 14a)
See more news about this stock »

Your Recent History
Iovance Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.